Table 4.
GEM-E | GEM | |
---|---|---|
(n = 1,331) | (n = 2,936) | |
Effectiveness | 325.6 days | 305.6 days |
(Overall mean survival time) | (0.894 year) | (0.839 year) |
Incremental Effectiveness | 20 days | - |
(0.055 year) | ||
Costa | USD 23,819.51 | USD 19,927.98 |
Incremental Cost | USD 3,891.53 | - |
Incremental Cost-Effectiveness Ratio (ICER) | USD 70,755.06/year | - |
Abbreviation: GEM Gemcitabine, GEM-E Gemcitabine + Erlotinib
aAverage 2013 exchange rate: one US dollar (USD) = 1,113.85 Korea Won (KRW)